Microglial inflammatory pathways

Microglial inflammatory pathways represent the coordinated signaling networks within the central nervous system's resident macrophages that mediate the brain's immune response (Wolf et al., 2017, Physiological Reviews). These pathways are triggered by various stimuli, including protein aggregates like amyloid-beta, cellular debris, and pathogens, primarily through receptors such as Toll-like receptors (TLRs) and TREM2 (Hansen et al., 2018, Journal of Cell Biology). Upon activation, microglia undergo morphological changes and release a suite of pro-inflammatory mediators, including cytokines like IL-1β and TNF-α, and reactive oxygen species, which can lead to chronic neuroinflammation and neuronal damage if left unchecked (Deczkowska et al., 2018, Cell). In neurodegenerative conditions like Alzheimer's and Parkinson's diseases, these pathways become dysregulated, contributing to disease progression (Hansen et al., 2018, Journal of Cell Biology). Therapeutic interventions targeting these pathways seek to shift microglia from a neurotoxic state to a neuroprotective or homeostatic state, or specifically inhibit components like the NLRP3 inflammasome to mitigate neuroinflammation (Subramaniam & Federoff, 2017, Neurotherapeutics).

Other names

Microglial activationNeuroinflammatory pathwaysMicroglial immune response

Modulation of microglial activation states, inhibition of pro-inflammatory cytokine production (e.g., IL-1β, TNF-α), and suppression of the NLRP3 inflammasome (Subramaniam & Federoff, 2017, Neurotherapeutics).